Latest news & insights
Latest news & insights

Partnerships
Fuse Oncology Showcases Live Clinical AI Solutions at ASTRO 2025
Fuse Oncology, a leader in AI-powered oncology workflow solutions, mission is to unify radiation oncology workflows through vendor-agnostic solutions that deliver real-world value. This vision will be on display at ASTRO, where GE HealthCare will feature Fuse solutions in its booth, underscoring the importance of collaboration and interoperability in advancing cancer care.
By seamlessly connecting across platforms, Fuse solutions are designed to improve efficiency, strengthen compliance, and reduce the administrative burden for care teams.
“Our goal is simple: eliminate unnecessary complexity in oncology workflows so that clinicians can spend more time with patients,” said James Bauler, CEO of Fuse Oncology. “By remaining vendor-agnostic, Fuse can deliver measurable improvements in efficiency, compliance, and revenue integrity across the entire ecosystem.”
Proven Impact Across Oncology Workflows
Fuse’s technology is already driving measurable results for cancer centers nationwide:
• S!GNAL has identified more than $168 million in charge capture corrections, demonstrating its significant financial and operational impact.
• FuseDocs saves physicians an average of 40 minutes per new patient start by automatically generating multiple clinical documents from consult through follow-up, including end-of-treatment notes. This reduces clicks and EHR time for care teams.
ASTRO attendees will experience firsthand how Fuse is redefining radiation oncology workflows with interoperable, vendor-agnostic solutions designed to streamline operations and free clinicians to focus on patient care.
About Fuse Oncology
Fuse Oncology is redefining cancer care with AI-powered, interoperable solutions built by industry insiders. Spun out of Cone Health in 2021 and powered by technology licensed from the University of Michigan, Fuse is realizing a bold vision: an end-to-end oncology workflow that enables providers to move at the speed of the patient™. From charge capture and documentation to clinical insights and analytics, Fuse helps oncology practices streamline operations, reduce burnout, and recover missed charges so clinicians can focus on patients, not paperwork.

Partnerships
Fuse Oncology Showcases Live Clinical AI Solutions at ASTRO 2025
Fuse Oncology, a leader in AI-powered oncology workflow solutions, mission is to unify radiation oncology workflows through vendor-agnostic solutions that deliver real-world value. This vision will be on display at ASTRO, where GE HealthCare will feature Fuse solutions in its booth, underscoring the importance of collaboration and interoperability in advancing cancer care.
By seamlessly connecting across platforms, Fuse solutions are designed to improve efficiency, strengthen compliance, and reduce the administrative burden for care teams.
“Our goal is simple: eliminate unnecessary complexity in oncology workflows so that clinicians can spend more time with patients,” said James Bauler, CEO of Fuse Oncology. “By remaining vendor-agnostic, Fuse can deliver measurable improvements in efficiency, compliance, and revenue integrity across the entire ecosystem.”
Proven Impact Across Oncology Workflows
Fuse’s technology is already driving measurable results for cancer centers nationwide:
• S!GNAL has identified more than $168 million in charge capture corrections, demonstrating its significant financial and operational impact.
• FuseDocs saves physicians an average of 40 minutes per new patient start by automatically generating multiple clinical documents from consult through follow-up, including end-of-treatment notes. This reduces clicks and EHR time for care teams.
ASTRO attendees will experience firsthand how Fuse is redefining radiation oncology workflows with interoperable, vendor-agnostic solutions designed to streamline operations and free clinicians to focus on patient care.
About Fuse Oncology
Fuse Oncology is redefining cancer care with AI-powered, interoperable solutions built by industry insiders. Spun out of Cone Health in 2021 and powered by technology licensed from the University of Michigan, Fuse is realizing a bold vision: an end-to-end oncology workflow that enables providers to move at the speed of the patient™. From charge capture and documentation to clinical insights and analytics, Fuse helps oncology practices streamline operations, reduce burnout, and recover missed charges so clinicians can focus on patients, not paperwork.

Partnerships
Fuse Oncology Showcases Live Clinical AI Solutions at ASTRO 2025
Fuse Oncology, a leader in AI-powered oncology workflow solutions, mission is to unify radiation oncology workflows through vendor-agnostic solutions that deliver real-world value. This vision will be on display at ASTRO, where GE HealthCare will feature Fuse solutions in its booth, underscoring the importance of collaboration and interoperability in advancing cancer care.
By seamlessly connecting across platforms, Fuse solutions are designed to improve efficiency, strengthen compliance, and reduce the administrative burden for care teams.
“Our goal is simple: eliminate unnecessary complexity in oncology workflows so that clinicians can spend more time with patients,” said James Bauler, CEO of Fuse Oncology. “By remaining vendor-agnostic, Fuse can deliver measurable improvements in efficiency, compliance, and revenue integrity across the entire ecosystem.”
Proven Impact Across Oncology Workflows
Fuse’s technology is already driving measurable results for cancer centers nationwide:
• S!GNAL has identified more than $168 million in charge capture corrections, demonstrating its significant financial and operational impact.
• FuseDocs saves physicians an average of 40 minutes per new patient start by automatically generating multiple clinical documents from consult through follow-up, including end-of-treatment notes. This reduces clicks and EHR time for care teams.
ASTRO attendees will experience firsthand how Fuse is redefining radiation oncology workflows with interoperable, vendor-agnostic solutions designed to streamline operations and free clinicians to focus on patient care.
About Fuse Oncology
Fuse Oncology is redefining cancer care with AI-powered, interoperable solutions built by industry insiders. Spun out of Cone Health in 2021 and powered by technology licensed from the University of Michigan, Fuse is realizing a bold vision: an end-to-end oncology workflow that enables providers to move at the speed of the patient™. From charge capture and documentation to clinical insights and analytics, Fuse helps oncology practices streamline operations, reduce burnout, and recover missed charges so clinicians can focus on patients, not paperwork.

Colleagues & Culture
Fuse Oncology Congratulates Dr. Chris Jahraus on Being Named a 2025 ASTRO Fellow
Aug 19, 2025

Colleagues & Culture
Fuse Oncology Congratulates Dr. Chris Jahraus on Being Named a 2025 ASTRO Fellow
Aug 19, 2025

Product Use Cases
Are You Measuring What Matters? How Data Transforms Code Capture and Compliance in Radiation Oncology
Jul 1, 2025

Product Use Cases
Are You Measuring What Matters? How Data Transforms Code Capture and Compliance in Radiation Oncology
Jul 1, 2025

Partnerships
Fuse Oncology Announces Partnership with Elekta
Jun 19, 2025

Partnerships
Fuse Oncology Announces Partnership with Elekta
Jun 19, 2025
All news
All news
Stay updated on use cases, news about Fuse and our ecosystem of oncology solutions helping you move at the speed of the patient.
ALL NEWS
PRODUCT USE CASES
PARTNERSHIPS
RESEARCH
COLLEAGUES & CULTURE

Fuse Oncology Showcases Live Clinical AI Solutions at ASTRO 2025
Sep 26, 2025

Fuse Oncology Congratulates Dr. Chris Jahraus on Being Named a 2025 ASTRO Fellow
Aug 19, 2025

Are You Measuring What Matters? How Data Transforms Code Capture and Compliance in Radiation Oncology
Jul 1, 2025

Fuse Oncology Announces Partnership with Elekta
Jun 19, 2025

Living in Bonus Time: A Fuse Survivor's Story
Jun 10, 2025

Technology's Answer to Physician Burnout: Automation Will Improve the Future of Rad Onc
May 27, 2025

Fuse Presents Poster at ACRO Examining AI’s Impact on Documentation
May 12, 2025

Fuse Oncology, ACRO Partner to Integrate Clinical Pathways Platform
Mar 13, 2025

Fuse Oncology Establishes Clinical Liaison Council
Mar 10, 2025

Technology Solutions Addressing Coding Burdens in Rad Onc
Jan 16, 2025

Navigating the Complexities of Healthcare Consolidation: Seamless Interoperability in Radiation Oncology
Nov 26, 2024

Poster Presentation at ASTRO Reveals Effective Way to Mitigate Charge Capture Errors
Oct 31, 2024
ALL NEWS
PRODUCT USE CASES
PARTNERSHIPS
RESEARCH
COLLEAGUES & CULTURE

Fuse Oncology Showcases Live Clinical AI Solutions at ASTRO 2025
Sep 26, 2025

Fuse Oncology Congratulates Dr. Chris Jahraus on Being Named a 2025 ASTRO Fellow
Aug 19, 2025

Are You Measuring What Matters? How Data Transforms Code Capture and Compliance in Radiation Oncology
Jul 1, 2025

Fuse Oncology Announces Partnership with Elekta
Jun 19, 2025

Living in Bonus Time: A Fuse Survivor's Story
Jun 10, 2025

Technology's Answer to Physician Burnout: Automation Will Improve the Future of Rad Onc
May 27, 2025

Fuse Presents Poster at ACRO Examining AI’s Impact on Documentation
May 12, 2025

Fuse Oncology, ACRO Partner to Integrate Clinical Pathways Platform
Mar 13, 2025

Fuse Oncology Establishes Clinical Liaison Council
Mar 10, 2025

Technology Solutions Addressing Coding Burdens in Rad Onc
Jan 16, 2025

Navigating the Complexities of Healthcare Consolidation: Seamless Interoperability in Radiation Oncology
Nov 26, 2024

Poster Presentation at ASTRO Reveals Effective Way to Mitigate Charge Capture Errors
Oct 31, 2024
ALL NEWS
PRODUCT USE CASES
PARTNERSHIPS
RESEARCH
COLLEAGUES & CULTURE

Fuse Oncology Showcases Live Clinical AI Solutions at ASTRO 2025
Sep 26, 2025

Fuse Oncology Congratulates Dr. Chris Jahraus on Being Named a 2025 ASTRO Fellow
Aug 19, 2025

Are You Measuring What Matters? How Data Transforms Code Capture and Compliance in Radiation Oncology
Jul 1, 2025

Fuse Oncology Announces Partnership with Elekta
Jun 19, 2025

Living in Bonus Time: A Fuse Survivor's Story
Jun 10, 2025

Technology's Answer to Physician Burnout: Automation Will Improve the Future of Rad Onc
May 27, 2025

Fuse Presents Poster at ACRO Examining AI’s Impact on Documentation
May 12, 2025

Fuse Oncology, ACRO Partner to Integrate Clinical Pathways Platform
Mar 13, 2025

Fuse Oncology Establishes Clinical Liaison Council
Mar 10, 2025

Technology Solutions Addressing Coding Burdens in Rad Onc
Jan 16, 2025

Navigating the Complexities of Healthcare Consolidation: Seamless Interoperability in Radiation Oncology
Nov 26, 2024

Poster Presentation at ASTRO Reveals Effective Way to Mitigate Charge Capture Errors
Oct 31, 2024
REQUEST A DISCOVERY SESSION
Ready to change your business?
Schedule a discovery session with a Fuse team member today. We’ll share in-depth product demonstrations and answer any questions about how FuseDocs and the Fuse Platform can help your organization.
REQUEST A DISCOVERY SESSION
Ready to change your business?
Schedule a discovery session with a Fuse team member today. We’ll share in-depth product demonstrations and answer any questions about how FuseDocs and the Fuse Platform can help your organization.
REQUEST A DISCOVERY SESSION
Ready to change your business?
Schedule a discovery session with a Fuse team member today. We’ll share in-depth product demonstrations and answer any questions about how FuseDocs and the Fuse Platform can help your organization.


OUR MISSION
Automation and efficiency lets clinicians focus on what matters most – patient care.


OUR MISSION
Automation and efficiency lets clinicians focus on what matters most – patient care.


OUR MISSION